相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Facile discovery of surrogate cytokine agonists
Michelle Yen et al.
CELL (2022)
Interleukin-2 superkines by computational design
Junming Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Caleb R. Glassman et al.
SCIENCE (2022)
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells
Caleb R. Glassman et al.
CELL (2021)
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)
J. Randolph Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design
Robert A. Saxton et al.
IMMUNITY (2021)
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
Bo Zhang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
Robert A. Saxton et al.
SCIENCE (2021)
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
Eric J. Hsu et al.
NATURE COMMUNICATIONS (2021)
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells
Katherine E. Harris et al.
SCIENTIFIC REPORTS (2021)
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist
Caleb R. Glassman et al.
ELIFE (2021)
Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain - A Review of Current Evidence
Hon Sen Tan et al.
JOURNAL OF PAIN RESEARCH (2021)
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Fei Mo et al.
NATURE (2021)
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism
Jerod L. Ptacin et al.
NATURE COMMUNICATIONS (2021)
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
Yuanming Xu et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress
Ivan S. Pires et al.
ADVANCED THERAPEUTICS (2021)
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
Inja Waldhauer et al.
MABS (2021)
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes et al.
SCIENCE (2020)
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
Aslan Mansurov et al.
NATURE BIOMEDICAL ENGINEERING (2020)
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Ting Zhou et al.
NATURE (2020)
Conformational Basis of G Protein-Coupled Receptor Signaling Versatility
Laura M. Wingler et al.
TRENDS IN CELL BIOLOGY (2020)
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
Claire Gorby et al.
SCIENCE SIGNALING (2020)
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
Liliane Khoryati et al.
SCIENCE IMMUNOLOGY (2020)
An engineered 4-1BBL fusion protein with activity on demand
Jacqueline Mock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
Dilara Sahin et al.
NATURE COMMUNICATIONS (2020)
IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation
Daniela Impellizzieri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Structure of the IFNγ receptor complex guides design of biased agonists
Juan L. Mendoza et al.
NATURE (2019)
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Wenjun Ouyang et al.
IMMUNITY (2019)
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Kritika Mohan et al.
SCIENCE (2019)
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Noor Momin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III- IV melanoma
Robert H. Andtbacka et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Treatment of type 2 diabetes with the designer cytokine IC7Fc
Maria Findeisen et al.
NATURE (2019)
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity
Jonathan Martinez-Fabregas et al.
ELIFE (2019)
De novo design of potent and selective mimics of IL-2 and IL-15
Daniel-Adriano Silva et al.
NATURE (2019)
Synthetic cytokine receptors transmit biological signals using artificial ligands
Erika Engelowski et al.
NATURE COMMUNICATIONS (2018)
Tuning the Cytokine Responses: An Update on interleukin (IL)-4 and IL-13 Receptor Complexes
Ilkka S. Junttila
FRONTIERS IN IMMUNOLOGY (2018)
The Molecular Basis of G Protein-Coupled Receptor Activation
William I. Weis et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy
Jamie B. Spangler et al.
JOURNAL OF IMMUNOLOGY (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
The molecular details of cytokine signaling via the JAK/STAT pathway
Rhiannon Morris et al.
PROTEIN SCIENCE (2018)
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
Laurence B. Peterson et al.
JOURNAL OF AUTOIMMUNITY (2018)
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
Juan L. Mendoza et al.
IMMUNITY (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers
Ignacio Moraga et al.
ELIFE (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation
Ah Ram Kim et al.
CELL (2017)
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases
Yuping Lai et al.
INTERNATIONAL IMMUNOLOGY (2016)
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal et al.
CELL (2016)
Immunocytokines for cancer treatment: past, present and future
Dario Neri et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation
Janine Woytschak et al.
IMMUNITY (2016)
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
Natalia Arenas-Ramirez et al.
Science Translational Medicine (2016)
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
Sarah L. Pogue et al.
PLOS ONE (2016)
Interleukin-22: Immunobiology and Pathology
Jarrod A. Dudakov et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Insights into Cytokine-Receptor Interactions from Cytokine Engineering
Jamie B. Spangler et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
Andreas Plueckthun
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
Jamie B. Spangler et al.
IMMUNITY (2015)
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
Suman Mitra et al.
IMMUNITY (2015)
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling
Stephan Wilmes et al.
JOURNAL OF CELL BIOLOGY (2015)
Agonist antibody that induces human malignant cells to kill one another
Kyungmoo Yea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Timo Rath et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors
Siri Tahtinen et al.
PLOS ONE (2015)
Therapeutic opportunities of the IL-22-IL-22R1 system
Robert Sabat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Interleukin-18 and IL-18 binding protein
Charles A. Dinarello et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
Nadine Pasche et al.
CLINICAL CANCER RESEARCH (2012)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
Jacob Piehler et al.
IMMUNOLOGICAL REVIEWS (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
Ilkka S. Junttila et al.
NATURE CHEMICAL BIOLOGY (2012)
Immunomodulatory functions of type I interferons
Jose M. Gonzalez-Navajas et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Christoph Thomas et al.
CELL (2011)
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Muebeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Interleukin-18: Biology and Role in the Immunotherapy of Cancer
S. Srivastava et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Interferon-Lambda: A New Addition to an Old Family
Raymond P. Donnelly et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents
Raymond P. Donnelly et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
Structural Biology of Shared Cytokine Receptors
Xinquan Wang et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Effective screening method of agonistic diabodies based on autocrine growth
Kiyotaka Nakano et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells
David V. Liu et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The structure and function of G-protein-coupled receptors
Daniel M. Rosenbaum et al.
NATURE (2009)
Cytokine signaling modules in inflammatory responses
John J. O'Shea et al.
IMMUNITY (2008)
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivity
Ilkka S. Junttila et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Gabriella Regis et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
An interferon α2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities
Eyal Kalie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differential receptor subunit affinities of Type I interferons govern differential signal activation
Eva Jaks et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Selective stimulation of T cell subsets with antibody-cytokine immune complexes
O Boyman et al.
SCIENCE (2006)
Inquiring into the differential action of interferons (IFNs):: an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β
DA Jaitin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Complex modulation of cell type-specific signaling in response to type I Interferons
Anette H. H. van Boxel-Dezaire et al.
IMMUNITY (2006)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
The structure of interleukin-2 complexed with its alpha receptor
M Rickert et al.
SCIENCE (2005)
Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon
KSA Khabar et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Structure-immunogenicity relationships of therapeutic proteins
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2004)
Recombinant erythropoietin in clinical practice
T Ng et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults - A randomized, dose-ranging study
MP Ettinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity
BM Rao et al.
PROTEIN ENGINEERING (2003)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Cytokine and cytokine receptor pleiotropy and redundancy
K Ozaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
N Casadevall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
S Fujii et al.
BLOOD (2001)
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2001)
分享论文
